10zyme offers a self-contained point‑of‑care test that detects all 14 high‑risk HPV types linked to cervical cancer, delivering an instant result without laboratory processing. By combining synthetic biology with a proprietary AI platform, the test provides accurate, on‑device readouts in minutes, enabling women to screen at home or in community settings and increasing overall screening uptake.
Funding
Funding not disclosed
Founders
Product
Problem
Many women lack timely access to cervical cancer screening because traditional methods require clinic visits, sample collection, and laboratory processing, leading to delays in results and low participation rates, especially in underserved populations.
Solution
10zyme has developed a self-contained diagnostic test that detects all 14 high‑risk HPV types—the viruses responsible for over 99% of cervical cancers—in a single step, delivering an instant result at the point of use. The test combines synthetic biology with a proprietary AI platform to generate a reliable readout without the need for sample transport or external lab equipment. By providing immediate feedback, the solution enables women to assess their cervical health wherever and whenever they choose, encouraging higher screening uptake and reducing pressure on healthcare services. The technology’s AI‑driven design also allows rapid adaptation to new diagnostic targets, extending its potential beyond HPV screening.
Target Audience
Primary users are women of screening‑eligible age, particularly those in regions with limited access to clinical services, as well as public health programs and primary‑care providers seeking to increase cervical screening coverage.
Features
- Fully integrated self‑test that produces a result within minutes, eliminating the need for laboratory analysis
- Detection of all 14 high‑risk HPV genotypes associated with cervical cancer
- Synthetic biology assay coupled with machine‑learning interpretation for accurate, on‑device readout
- Portable, user‑friendly format suitable for home use or community settings
- Scalable AI platform that can be reprogrammed to develop additional point‑of‑care diagnostics